Z Squared Inc.ZSQR
Price (close)
$3.71
Market cap
$196.6M
P/E
—
Revenue (TTM)
$2.8M
Net income
-$18.0M
Dividend yield
—
1-year total return
-77.7%
Net margin
-642.0%
Revenue growth
4348.2%
Debt / equity
0.00x
What Z Squared Inc. does.
in this Annual Report on Form 10-K, pursuant to the Merger, we acquired our primary operating subsidiary Coeptis Therapeutics, Inc. Since
prior to the Merger the Company was a shell company, the business description below is a description of the Company’s business based
were originally incorporated in the British Virgin Islands on November 27, 2018, under the name Bull Horn Holdings Corp. On October 27,
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $75,000 | $0 | $0 | $0 | $1.4M |
| Net income | -$17.3M | -$13.4M | -$37.6M | -$21.3M | -$10.7M | -$11.9M |
More on ZSQR.
- Z Squared Inc. summary
- Z Squared Inc. financial statements
- Z Squared Inc. key metrics
- Z Squared Inc. health scores and style box
- Z Squared Inc. earnings
- Z Squared Inc. dividends
- Z Squared Inc. valuation
- Z Squared Inc. ownership and insiders
- Z Squared Inc. peers
Figures from Z Squared Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.